Returning for its third year, Grand Rounds U.S. brings together pharma leaders, venture capital investors, biotech executives, academic innovators, and founders for three days of high-level networking and in-depth scientific discussion.
Early-stage translation at the academia-industry interface remains one of the most complex and underleveraged areas in biopharma. Grand Rounds is designed specifically around this challenge, focusing on three critical areas where translational bottlenecks most often emerge: emerging disease biology, discovery-enabling tools and technologies, and therapeutic modality design.
As a Life Science Washington community member, you are already working within this early-stage drug and diagnostic development ecosystem. Grand Rounds offers a rare opportunity to engage directly with peers and decision-makers who understand the scientific and translational challenges at the depth your work demands.
Register using the LSW Member Discount Code: GR26LSW
Visit here for more information.